Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 8/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29847389 | 0.86 | ALDH1A1 (0.49) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL2338368 | 0.86 | ALDH1A1 (0.49) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL7962015 | 0.86 | ALDH1A1 (0.49) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL7962011 | 0.86 | ALDH1A1 (0.49) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL13651811 | 0.85 | ALDH1A1 (0.60) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL4177996 | 0.83 | ALDH1A1 (0.46) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL3354399 | 0.83 | ALDH1A1 (0.46) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL4947451 | 0.83 | ALDH1A1 (0.54) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL30161198 | 0.83 | TTR (0.45) | ALDH1A1GLATSHRTP53CYP3A4 | |
| SCHEMBL2230996 | 0.83 | TTR (0.45) | ALDH1A1GLATSHRTP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110467795-B | Low-viscosity liquid oxygen compatible epoxy resin system for wet-process fiber winding and preparation method thereof | 大连理工大学 | 2021-02-23 | — | — | CN | claimed |
| CN-110467795-A | A kind of low viscosity liquid oxygen compatible epoxy system and preparation method thereof for wet laid fiber winding | UNIV DALIAN TECH | 2019-11-19 | — | — | CN | claimed |
| CN-110467795-B | Low-viscosity liquid oxygen compatible epoxy resin system for wet-process fiber winding and preparation method thereof | 大连理工大学 | 2021-02-23 | — | — | CN | disclosed |
| CN-110467795-A | A kind of low viscosity liquid oxygen compatible epoxy system and preparation method thereof for wet laid fiber winding | UNIV DALIAN TECH | 2019-11-19 | — | — | CN | disclosed |
| US-20190092727-A1 | Piperidine Compounds, Pharmaceutical Composition Comprising The Same And Its Use | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2019-03-28 | — | — | US | disclosed |
| US-10144709-B2 | Piperidine compounds, pharmaceutical composition comprising the same and its use | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2018-12-04 | — | — | US | disclosed |
| CN-105646331-B | Piperidine compounds, the medical composition and its use containing the compound | 爱思开生物制药株式会社 | 2018-07-03 | — | — | CN | disclosed |
| US-20170275250-A1 | PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AND ITS USE | SK BIOPHARMACEUTICALS CO LTD (KR) | 2017-09-28 | — | — | US | disclosed |
| US-9676718-B2 | Piperidine compounds, pharmaceutical composition comprising the same and its use | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2017-06-13 | — | — | US | disclosed |
| US-9593102-B2 | Piperidine compounds, pharmaceutical composition comprising the same and its use | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2017-03-14 | — | — | US | disclosed |
| US-20160362374-A1 | PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AND ITS USE | SK BIOPHARMACEUTICALS CO LTD (KR) | 2016-12-15 | — | — | US | disclosed |
| US-4604468-A | ADRENERIC BLOCKING AGENTS, ANTIDEPRESSANT | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 1986-08-05 | — | — | US | disclosed |
| US-4438128-A | ADRENERGIC BLOCKERS | BOEHRINGER MANNHEIM GMBH (DE) | 1984-03-20 | — | — | US | disclosed |
| US-4381309-A | ADRENERGIC BLOCKING AGENTS; ANTIDEPRESSANTS | BOEHRINGER INGELHEIM GMBH (DE) | 1983-04-26 | — | — | US | disclosed |
| US-4343800-A | ANTIDEPRESSANTS; ADRENERGIC BLOCKING, HYPOTENSIVE, AND ANTIARRHYTHMIA AGENTS | BOEHRINGER INGELHEIM GMBH (DE) | 1982-08-10 | — | — | US | disclosed |
| US-4296117-A | ADRENERGIC BLOCKING AGENTS, ANTIDEPRESSANTS | BOEHRINGER INGELHEIM GMBH (DE) | 1981-10-20 | — | — | US | disclosed |
| US-4256756-A | ADRENERGIC BLOCKING AGENTS, ANTIDEPRESSANTS | BOEHRINGER INGELHEIM GMBH (DE) | 1981-03-17 | — | — | US | disclosed |
| US-4255430-A | ANDRENERGIC RECEPTOR BLOCKING AGENTS | BOEHRINGER INGELHEIM GMBH (DE) | 1981-03-10 | — | — | US | disclosed |
| US-4212877-A | ANTIDEPRESSANTS, ADRENERGIC BLOCKING AGENTS | BOEHRINGER INGELHEIM GMBH (DE) | 1980-07-15 | — | — | US | disclosed |
| US-4110472-A | CEREBROVASCULAR INSUFFICIENCY, PSYCHOSTIMULATION | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275250-A1 | PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AND ITS USE | PGC, VIP, PIGO | ALDH1A1 365/4885GLA 3931/4885TSHR 3988/4885 |
| US-10144709-B2 | Piperidine compounds, pharmaceutical composition comprising the same and its use | PGC, VIP, PIGO | ALDH1A1 365/4885GLA 3931/4885TSHR 3988/4885 |
| US-20190092727-A1 | Piperidine Compounds, Pharmaceutical Composition Comprising The Same And Its Use | PGC, VIP, PIGO | ALDH1A1 365/4885GLA 3931/4885TSHR 3988/4885 |
| US-20160362374-A1 | PIPERIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AND ITS USE | PGC, VIP, PIGO | ALDH1A1 365/4885GLA 3931/4885TSHR 3988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.